Inventor · disambiguated record
Robert E. Lee Trout
Also filed as: TROUT ROBERT · TROUT ROBERT E LEE
24 granted patents·6 pending applications·331 citations·filing 2006–2024
96Inventor score
Top patents by PatentIndex Score
30 records- 0198US9511142B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·50 cites·19 claims
- 0296US10669290B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Jun 2, 2020·8 cites·18 claims
- 0396US9783555B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Oct 10, 2017·15 cites·20 claims
- 0496US9376454B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Granted Jun 28, 2016·24 cites·20 claims
- 0596US9040504B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted May 26, 2015·34 cites·18 claims
- 0696US8912169B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2013·Granted Dec 16, 2014·34 cites·20 claims
- 0795US9828391B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Nov 28, 2017·15 cites·16 claims
- 0895US9802966B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Oct 31, 2017·10 cites·20 claims
- 0995US9637504B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted May 2, 2017·19 cites·18 claims
- 1095US9403850B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted Aug 2, 2016·25 cites·20 claims
- 1194US10294248B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted May 21, 2019·7 cites·20 claims
- 1294US10214547B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Feb 26, 2019·10 cites·10 claims
- 1394US9771382B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Sep 26, 2017·15 cites·19 claims
- 1494US9422314B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2013·Granted Aug 23, 2016·22 cites·21 claims
- 1593US9944658B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted Apr 17, 2018·10 cites·19 claims
- 1693US9926336B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Mar 27, 2018·12 cites·20 claims
- 1792US10294247B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·20 claims
- 1891US11008346B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2020·Granted May 18, 2021·2 cites·20 claims
- 1991US10125152B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Nov 13, 2018·8 cites·20 claims
- 2089US2025236632A1Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2184US10464952B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Nov 5, 2019·5 cites·13 claims
- 2270US11414435B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2020·Granted Aug 16, 2022·0 cites·20 claims
- 2355US2017145037A1Orally bioavailable beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2451US2015361108A1Orally bioavailable beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2549US7902394B2Calcilytic compoundsGLAXOSMITHKLINE LLC·Filed 2007·Granted Mar 8, 2011·0 cites·17 claims
- 2649US2022194964A1Solid forms of an orally-delivered beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2745US12173018B2Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Dec 24, 2024·0 cites·17 claims
- 2844US2009137557A1Calcilytic CompoundsKU THOMAS WEN FU·Filed 2006·Application pending·0 cites
- 2941US11332485B2Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted May 17, 2022·0 cites·16 claims
- 3035US2015361107A1Orally bioavailable beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert E. Lee Trout files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →